designed to reduce severe heart attack impairment when used as an adjunct therapy with angioplasty in acute STEMI and NSTEMI patients. Company appoints Cajetan von König as Director of Sales and ...

AWANS, Belgium--(BUSINESS WIRE)--Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO ® Impulse System for ...

VIENNA, Austria - Miracor Medical Systems announced today that results from the ‘Prepare RAMSES’ clinical trial will be disclosed at ‘TCT 2014’ in Washington, D.C. The Prepare RAMSES trial was a ...

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--Impulse Dynamics, developer of the implantable Optimizer Smart System for delivering Cardiac Contractility Modulation (also known as CCM™ therapy), announced that ...